# Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury

> **NCT05616910** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **University of Pennsylvania** · enrollment: 38 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** inhaled nitric oxide

## Key facts

- **NCT ID:** NCT05616910
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-06
- **Primary completion:** 2028-03-28
- **Final completion:** 2028-03-28
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05616910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05616910, "Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT05616910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*